No Data
No Data
Express News | Forte Biosciences Files for Offer & Resale From Time to Time of up to 9.5 Mln Shares of Common Stock by Selling Stockholders - SEC Filing
Express News | Chardan Capital Maintains Buy on Forte Biosciences, Maintains $64 Price Target
Forte Biosciences to Host R&D Day December 3, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
Quantum-Si QSI SKYT & NVDA Deal; Forte Biosciences FBRX Equity Financing